ERIC QUINTANILLA: Open Payments
NPI 1376259440 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$862 in 23 payments from 11 companies in 2025. Trend: 2023 $1,137 · 2024 $1,513 · 2025 $862
Food & beverage: $862
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 4 | $289 |
| Globus Medical, Inc. | 1 | $133 |
| SI-BONE, INC. | 1 | $109 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $74 |
| Exact Sciences Corporation | 3 | $54 |
| AstraZeneca Pharmaceuticals LP | 3 | $47 |
| ABBVIE INC. | 2 | $45 |
| Amgen Inc. | 2 | $36 |
| PFIZER INC. | 2 | $35 |
| Axsome Therapeutics, Inc. | 1 | $23 |
Products named: Senza, JARDIANCE, KISUNLA, Kerendia, The Cologuard Plus Collection Kit, MOUNJARO, OTEZLA, FARXIGA.
Industry payments across TX — which companies pay providers there.
